Literature DB >> 20060018

The history of the cholinergic hypothesis.

Antonio Contestabile1.   

Abstract

The cholinergic hypothesis of cognitive impairment and Alzheimer's disease has been for decades a "polar star" for studies on dementia and neurodegenerative diseases. Aim of the present article is to briefly summarize its birth and its evolution throughout years and discoveries. Putting the cholinergic hypothesis in an historical perspective, allows to appreciate the enormous amount of experimental and clinical research that it has stimulated over years and the impressive extent of knowledge generated by this research. While some of the assumptions at the basis of its original formulation are disputable in the light of recent developments, the cholinergic hypothesis has, however, constituted an invaluable stimulus to better understand not only the anatomy and the biochemistry of the cholinergic systems of brain connections but also its developmental biology, its complex relationships with trophic factors, its role in cognitive functions. Thus, rather than being consigned to history, the cholinergic hypothesis will likely contribute to further understanding dementia and neurodegenerative diseases and will hopefully be integrated in novel therapies and treatments.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060018     DOI: 10.1016/j.bbr.2009.12.044

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  73 in total

1.  Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.

Authors:  Hongjun Jin; Xiang Zhang; Xuyi Yue; Hui Liu; Junfeng Li; Hao Yang; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Nucl Med Biol       Date:  2015-11-07       Impact factor: 2.408

Review 2.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

3.  Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.

Authors:  Onnita Thancharoen; Chulaporn Limwattananon; Onanong Waleekhachonloet; Thananan Rattanachotphanit; Phumtham Limwattananon; Panita Limpawattana
Journal:  Drugs Aging       Date:  2019-05       Impact factor: 3.923

4.  Cholinergic blockade reduces theta-gamma phase amplitude coupling and speed modulation of theta frequency consistent with behavioral effects on encoding.

Authors:  Ehren L Newman; Shea N Gillet; Jason R Climer; Michael E Hasselmo
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

5.  UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ1-42.

Authors:  Mingyong Zhang; Yue Liu; Min Liu; Biying Liu; Na Li; Xin Dong; Zhanying Hong; Yifeng Chai
Journal:  Metabolomics       Date:  2019-01-17       Impact factor: 4.290

6.  Neuroprotective Effects of 2-Substituted 1, 3-Selenazole Amide Derivatives on Amyloid-Beta-Induced Toxicity in a Transgenic Caenorhabditis Elegans Model of Alzheimer's Disease.

Authors:  Huiying Wang; Yuandong Yue; Haifeng Zhao; Hao Wu; Kai Jiang; Shuang Li; Meihua Zhao; Feng Lin
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

Review 7.  Eye movements in Alzheimer's disease.

Authors:  Robert J Molitor; Philip C Ko; Brandon A Ally
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Brain Network Activation (BNA) reveals scopolamine-induced impairment of visual working memory.

Authors:  Amit Reches; Naama Levy-Cooperman; Ilan Laufer; Revital Shani-Hershkovitch; Keren Ziv; Dani Kerem; Noga Gal; Yaki Stern; Guy Cukierman; Myroslava K Romach; Edward M Sellers; Amir B Geva
Journal:  J Mol Neurosci       Date:  2014-02-18       Impact factor: 3.444

9.  Malignant synaptic growth and Alzheimer's disease.

Authors:  Ehren L Newman; Christopher F Shay; Michael E Hasselmo
Journal:  Future Neurol       Date:  2012-09

Review 10.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.